Janus Henderson Group PLC bought a new position in Catalent Inc (NASDAQ:CTLT) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 6,827,045 shares of the company’s stock, valued at approximately $239,629,000. Janus Henderson Group PLC owned 5.46% of Catalent at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently made changes to their positions in CTLT. Acrospire Investment Management LLC boosted its stake in Catalent by 72.2% in the 2nd quarter. Acrospire Investment Management LLC now owns 3,100 shares of the company’s stock worth $109,000 after purchasing an additional 1,300 shares during the period. Quantbot Technologies LP boosted its stake in Catalent by 110.7% in the 2nd quarter. Quantbot Technologies LP now owns 3,434 shares of the company’s stock worth $120,000 after purchasing an additional 1,804 shares during the period. PNC Financial Services Group Inc. boosted its stake in Catalent by 66.5% in the 1st quarter. PNC Financial Services Group Inc. now owns 6,070 shares of the company’s stock worth $173,000 after purchasing an additional 2,425 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in Catalent by 12.5% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 5,043 shares of the company’s stock worth $177,000 after purchasing an additional 559 shares during the period. Finally, Advisor Group Inc. boosted its stake in Catalent by 1.3% in the 2nd quarter. Advisor Group Inc. now owns 5,185 shares of the company’s stock worth $180,000 after purchasing an additional 65 shares during the period.

In other news, SVP Christine Dolan sold 745 shares of the business’s stock in a transaction that occurred on Tuesday, August 1st. The shares were sold at an average price of $34.85, for a total value of $25,963.25. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website.

A number of equities analysts recently weighed in on CTLT shares. Zacks Investment Research lowered shares of Catalent from a “buy” rating to a “hold” rating in a research note on Friday, September 1st. Bank of America Corporation reaffirmed a “buy” rating and issued a $40.00 target price (up from $38.00) on shares of Catalent in a research note on Tuesday, August 29th. Piper Jaffray Companies reaffirmed a “buy” rating and issued a $45.00 target price on shares of Catalent in a research note on Tuesday, August 29th. William Blair reaffirmed an “ourperform” rating on shares of Catalent in a research note on Tuesday, August 29th. Finally, ValuEngine raised shares of Catalent from a “hold” rating to a “buy” rating in a research note on Thursday, September 7th. Five analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus price target of $38.64.

TRADEMARK VIOLATION WARNING: “Janus Henderson Group PLC Buys Shares of 6,827,045 Catalent Inc (CTLT)” was published by Watch List News and is owned by of Watch List News. If you are viewing this piece of content on another publication, it was copied illegally and republished in violation of United States & international trademark and copyright law. The original version of this piece of content can be read at https://www.watchlistnews.com/janus-henderson-group-plc-buys-shares-of-6827045-catalent-inc-ctlt/1615138.html.

Catalent Inc (CTLT) opened at 42.29 on Friday. The firm has a market capitalization of $5.29 billion and a P/E ratio of 48.61. The stock’s 50 day moving average is $39.48 and its 200-day moving average is $34.78. Catalent Inc has a 1-year low of $21.83 and a 1-year high of $42.63.

Catalent (NASDAQ:CTLT) last released its quarterly earnings results on Monday, August 28th. The company reported $0.65 earnings per share for the quarter, topping the consensus estimate of $0.57 by $0.08. Catalent had a net margin of 10.02% and a return on equity of 36.29%. The business had revenue of $616.90 million for the quarter, compared to analysts’ expectations of $547.48 million. During the same period in the previous year, the company earned $0.52 earnings per share. The firm’s revenue for the quarter was up 15.9% compared to the same quarter last year. Analysts forecast that Catalent Inc will post $1.62 EPS for the current year.

Catalent Company Profile

Catalent, Inc provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products. Its segments include Softgel Technologies, Drug Delivery Solutions and Clinical Supply Services. The Softgel Technologies segment is engaged in the formulation, development and manufacturing of prescription and consumer health soft capsules or softgels.

Institutional Ownership by Quarter for Catalent (NASDAQ:CTLT)

Receive News & Ratings for Catalent Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catalent Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.